Place · Level 3 · Macro
Alcohol Metabolism
ADH → 乙醛 → ALDH2 → 乙酸 · 东亚 ALDH2*2 6 亿人 · IARC 1 类致癌物 · 适量护心 J 曲线被推翻
Story path
Chapter 1
Ethanol · the molecule
Ethanol · the molecule
Ethanol (CH₃CH₂OH) is a small, simple, fast-moving molecule. Molecular weight is only 46 g/mol — four times smaller than glucose (180 g/mol). It's also amphipathic, with a water-soluble hydroxyl (-OH) and a fat-soluble ethyl (-CH₂CH₃). Being small and amphipathic means ethanol crosses every membrane in the body without a transporter — stomach, gut, liver, brain, heart, gonads, bone marrow, no exception. It also doesn't need to be digested: blood ethanol is measurable 5–10 minutes after drinking and peaks at 30–60 minutes.
The route into the body is short: about 20% is absorbed directly in the stomach (faster on an empty stomach; food slows gastric emptying), and the remaining 80% in the upper small intestine; from there it enters the portal vein and the first stop is the liver — which is why the liver is always the main battlefield for alcohol metabolism.
There's a caloric trap: ethanol provides 7 kcal/g, sitting between carbohydrate (4), protein (4), and fat (9), but those calories are nearly empty — no vitamins, minerals, or fiber. One US 'standard drink' is 14 g of pure ethanol (the UK uses 8 g and Japan 20 g), roughly 350 ml of beer, 150 ml of red wine (12% ABV), or 45 ml of spirits (40% ABV), all landing around 98 kcal.
In the end, ethanol is a small toxic solvent the body has no metabolic role for and must immediately get rid of. The next four scenes show how the body handles it — and the real damage produced along the way.
Fitnuhealth doesn't moralize about drinking on this island; it just lays out mechanism and evidence clearly. All the latest evidence (GBD 2018 Lancet / Anderson 2022 NEJM) converges on the same conclusion: safe drinking quantity = 0 — any dose carries measurable health cost. So what we're doing here is letting you make your own informed choice after understanding the mechanism.
The route into the body is short: about 20% is absorbed directly in the stomach (faster on an empty stomach; food slows gastric emptying), and the remaining 80% in the upper small intestine; from there it enters the portal vein and the first stop is the liver — which is why the liver is always the main battlefield for alcohol metabolism.
There's a caloric trap: ethanol provides 7 kcal/g, sitting between carbohydrate (4), protein (4), and fat (9), but those calories are nearly empty — no vitamins, minerals, or fiber. One US 'standard drink' is 14 g of pure ethanol (the UK uses 8 g and Japan 20 g), roughly 350 ml of beer, 150 ml of red wine (12% ABV), or 45 ml of spirits (40% ABV), all landing around 98 kcal.
In the end, ethanol is a small toxic solvent the body has no metabolic role for and must immediately get rid of. The next four scenes show how the body handles it — and the real damage produced along the way.
Fitnuhealth doesn't moralize about drinking on this island; it just lays out mechanism and evidence clearly. All the latest evidence (GBD 2018 Lancet / Anderson 2022 NEJM) converges on the same conclusion: safe drinking quantity = 0 — any dose carries measurable health cost. So what we're doing here is letting you make your own informed choice after understanding the mechanism.
Why ethanol is its own macro
Ethanol is sometimes called the 'fourth macronutrient' beyond carbohydrate / fat / protein, but textbooks rarely label it that way — it's not an essential nutrient, has no RDA, and doesn't build any body tissue.But it does supply energy, and the way that energy is handled is unusual. 1 g ethanol = 7 kcal, but the body has no ethanol storage compartment: liver cells must process it immediately and cannot bank it like glucose as glycogen or fat as triglyceride. Drinking therefore forces the body's fuel order to rearrange: burn ethanol first (because it continuously produces toxic acetaldehyde and cannot wait), then glucose, and only finally fat. The consequence is that fat oxidation pauses for 1–3 hours — one of the metabolic roots of 'beer belly' and chronic-drinking-induced fatty liver.
Set alongside the three classical macronutrients, ethanol's oddness becomes clearer:
| Macro | kcal/g | Essential | Storable | Must burn first |
|---|---|---|---|---|
| Carbohydrate | 4 | No (theoretically) | Glycogen + convert to fat | No |
| Protein | 4 | Yes | No storage (amino acid pool) | No |
| Fat | 9 | Partially essential | Large depot | No |
| Ethanol | 7 | No | None at all | Yes |
Looking at 'calories from alcoholic beverages': almost entirely empty calories. Beer also contains carbohydrate (one can at 5% ABV ≈ 14 g ethanol + 12 g carbs ≈ 145 kcal); sweet wines and liqueurs contain more sugar (a glass at 200–300 kcal); dry red, dry white, and spirits are nearly pure ethanol calories. So 'drinking to lose weight' is physiologically incoherent — ethanol is 7 kcal/g you're forced to burn, and it simultaneously blocks fat oxidation.
Chapter 2
Liver: ADH → ALDH2
Liver: ADH → ALDH2
Hepatic alcohol metabolism runs in two steps, and understanding these two steps is the starting point for understanding all alcohol-related harm.
Step 1 is catalyzed by ADH (alcohol dehydrogenase), mostly in hepatocyte cytosol, with a small contribution in gastric mucosa.
```
ethanol + nicotinamide adenine dinucleotide: A coenzyme that ferries electrons to drive energy production — built from vitamin B3. → acetaldehyde + NADH + H⁺
CH₃CH₂OH + NAD⁺ → CH₃CHO + NADH + H⁺
```
Two consequences are worth remembering: the by-product NADH accumulates massively, lowering the liver's NAD⁺/NADH ratio and along with it raising fat synthesis, reducing gluconeogenesis, and piling up lactate; and the product acetaldehyde (CH₃CHO) is the real toxin, 30–100× more toxic than ethanol itself.
Step 2 is catalyzed by ALDH2 (aldehyde dehydrogenase 2) in hepatocyte mitochondria:
```
acetaldehyde + NAD⁺ + H₂O → acetate + NADH + H⁺
CH₃CHO + NAD⁺ → CH₃COOH + NADH
```
This step quickly converts the carcinogenic, DNA-adduct-forming acetaldehyde into relatively harmless acetate (CH₃COO⁻), which enters the bloodstream and is used as fuel by the heart, muscle, brain, and other tissues — turning into acetyl-CoA, entering the tricarboxylic acid (Krebs) cycle: The mitochondrial hub cycle that fully oxidizes fuel and harvests electrons for energy. cycle, and burning down to CO₂ + H₂O.
A few often-overlooked facts about the rate:
Healthy adult hepatic ethanol metabolism is roughly 7–10 g/hour, equivalent to one standard drinkThis is near zero-order — the rate is almost independent of blood concentration because ADH has long since saturatedWomen's hepatic rate is 20–30% lower than men's (body size, ADH activity, and body water fraction all contribute)'Drinking slowly' works because it gives the liver time to process; 'hangover pills / sobriety teas' contain nothing that actually speeds either enzyme up (next scene)
The single most critical molecule in this chain is acetaldehyde. It was placed on IARC's Group 1 carcinogen list long ago — the carcinogen is acetaldehyde, not ethanol itself. The next scene explains why this matters specifically to 600 million East Asians.
Step 1 is catalyzed by ADH (alcohol dehydrogenase), mostly in hepatocyte cytosol, with a small contribution in gastric mucosa.
```
ethanol + nicotinamide adenine dinucleotide: A coenzyme that ferries electrons to drive energy production — built from vitamin B3. → acetaldehyde + NADH + H⁺
CH₃CH₂OH + NAD⁺ → CH₃CHO + NADH + H⁺
```
Two consequences are worth remembering: the by-product NADH accumulates massively, lowering the liver's NAD⁺/NADH ratio and along with it raising fat synthesis, reducing gluconeogenesis, and piling up lactate; and the product acetaldehyde (CH₃CHO) is the real toxin, 30–100× more toxic than ethanol itself.
Step 2 is catalyzed by ALDH2 (aldehyde dehydrogenase 2) in hepatocyte mitochondria:
```
acetaldehyde + NAD⁺ + H₂O → acetate + NADH + H⁺
CH₃CHO + NAD⁺ → CH₃COOH + NADH
```
This step quickly converts the carcinogenic, DNA-adduct-forming acetaldehyde into relatively harmless acetate (CH₃COO⁻), which enters the bloodstream and is used as fuel by the heart, muscle, brain, and other tissues — turning into acetyl-CoA, entering the tricarboxylic acid (Krebs) cycle: The mitochondrial hub cycle that fully oxidizes fuel and harvests electrons for energy. cycle, and burning down to CO₂ + H₂O.
A few often-overlooked facts about the rate:
Healthy adult hepatic ethanol metabolism is roughly 7–10 g/hour, equivalent to one standard drinkThis is near zero-order — the rate is almost independent of blood concentration because ADH has long since saturatedWomen's hepatic rate is 20–30% lower than men's (body size, ADH activity, and body water fraction all contribute)'Drinking slowly' works because it gives the liver time to process; 'hangover pills / sobriety teas' contain nothing that actually speeds either enzyme up (next scene)
The single most critical molecule in this chain is acetaldehyde. It was placed on IARC's Group 1 carcinogen list long ago — the carcinogen is acetaldehyde, not ethanol itself. The next scene explains why this matters specifically to 600 million East Asians.
Redox shift
The two-step ADH + ALDH2 reactions each produce 1 NADH, so a single 14 g drink generates about 0.6 mol of NADH — enough to short-term drop the hepatic mitochondrial nicotinamide adenine dinucleotide: A coenzyme that ferries electrons to drive energy production — built from vitamin B3./NADH ratio from about 700 to about 300 (Lieber 2004). That one number alone can explain most of the metabolic imbalance of acute drinking.The main pathways disrupted:
tricarboxylic acid (Krebs) cycle: The mitochondrial hub cycle that fully oxidizes fuel and harvests electrons for energy. cycle slows — isocitrate → α-ketoglutarate and malate → oxaloacetate both need NAD⁺; once the ratio drops, lactate accumulates, urate excretion stalls, and gout flares more easilyβ-oxidation pauses — β-hydroxyacyl-CoA dehydrogenase also needs NAD⁺, so fat won't burn; meanwhile acetyl-CoA pours into de novo lipogenesis, converting to fatty acids and triglycerides — the chemical root of alcoholic fatty liverGluconeogenesis stops — lactate/pyruvate ratio rises and α-ketoglutarate falls, hepatic glucose production halts; this is why fasting + alcohol triggers hypoglycemia, especially dangerous in diabetics on insulin or sulfonylureasKetogenesis rises — when drinking fasted, acetyl-CoA piles up, TCA is full, and the path into fat synthesis is blocked; ketones accumulate as the alcoholic ketoacidosis (AKA) seen in emergency departments
Chronic drinking also activates a second pathway: CYP2E1 is induced (this one is NADPH-dependent, not NADH), producing large amounts of ROS that further damage the liver and creating a very dangerous interaction with acetaminophen (Tylenol) — a chronic drinker on a normal Tylenol dose can develop acute liver failure (see hepatic/phase-1-cyp L4).
Looking back at 'drinking makes you fat': the true cause isn't simply 'beer is high in calories' but NADH accumulation blocking β-oxidation while simultaneously pushing DNL. So low-sugar low-cal craft beer, dry red, and hard seltzer don't solve fat accumulation either.
The clinical course of alcoholic liver disease usually goes: fatty liver (steatosis) → alcoholic hepatitis → fibrosis → cirrhosis → hepatocellular carcinoma. Quitting is fully reversible at the fatty liver and early hepatitis stages, partially reversible at fibrosis, and irreversible once cirrhosis sets in.
Chapter 3
ALDH2*2 · East-Asian flush
ALDH2*2 · East-Asian flush
**ALDH2*2 (rs671, Glu504Lys)** is the most common enzyme-inactivating mutation on Earth with major clinical consequences, and it essentially only appears in East Asia.
Geographic distribution (Brooks 2009 PLoS Med):
East Asia (China / Japan / Korea / Vietnam): carrier rate 35–45%, ~600 million peopleEurope / Africa / Native Americans: < 1%Southeast Asia / India: 5–15%
Biochemically, the heterozygote (E/K) drops enzyme activity to 60–70%; the homozygote (K/K) drops to ~95% — near-complete inactivation.
Clinical presentation usually appears 5–30 minutes after drinking: flushing of the face, neck, and chest (acetaldehyde dilates vessels); 40–50% of people see heart rate climb past 100 bpm; accompanied by headache, nausea, and sweating. 'A couple of sips and they're dizzy and flushed' — that's the classic ALDH2*2 carrier picture.
This isn't 'intolerance' — it's 'acetaldehyde piling up in the blood'. For the same drink, the carrier's blood acetaldehyde peak can reach 6–10× the non-carrier's (Yokoyama 2007). Acetaldehyde is an IARC Group 1 carcinogen and forms DNA adducts, so that 6–10× translates directly into 6–10× the actual carcinogen exposure.
Clinical consequences:
Esophageal cancer — daily-drinking ALDH2*2 carriers face 50–80× higher esophageal squamous-cell carcinoma risk vs non-carrier non-drinkers (Yokoyama 2002 NEJM), one of the strongest known gene–environment interactions in human diseaseHead-and-neck and gastric cancer — same direction, 5–20× elevationsCoronary heart disease — some studies show elevated risk; the mechanism is likely acetaldehyde damage to vascular endothelium, plus ALDH2 also plays a role in cardiac metabolism of nitroglycerin, so carriers see blunted efficacy of the emergency drugWomen + carrier + drinking — elevated osteoporosis risk
Practical implications, especially relevant for Chinese / Japanese / Korean readers:
If you flush when you drink, you're very likely an ALDH2*2 carrier'Drinking to build tolerance' is the wrong concept here — what people call tolerance is brain adaptation to ethanol (GABA receptor down-regulation), but the acetaldehyde in your blood is unchanged, so the carcinogenic damage is the same or worseThere is no antidote: no nutritional supplement can restore ALDH2 activity (it's genetic), and every 'ALDH2 booster' on the market is marketing languageThe only effective intervention is dramatically reducing or stopping drinkingClinically, disulfiram (Antabuse) — an ALDH2 inhibitor — is used as alcoholism therapy, which is essentially proof that this reaction itself functions as a deterrent
Bottom line is direct: if you're East Asian and flush when you drink, that isn't 'weakness' — it's your body's protective mechanism still working. It's an evolutionary-level warning written in your genes; don't try to override it with willpower.
Geographic distribution (Brooks 2009 PLoS Med):
East Asia (China / Japan / Korea / Vietnam): carrier rate 35–45%, ~600 million peopleEurope / Africa / Native Americans: < 1%Southeast Asia / India: 5–15%
Biochemically, the heterozygote (E/K) drops enzyme activity to 60–70%; the homozygote (K/K) drops to ~95% — near-complete inactivation.
Clinical presentation usually appears 5–30 minutes after drinking: flushing of the face, neck, and chest (acetaldehyde dilates vessels); 40–50% of people see heart rate climb past 100 bpm; accompanied by headache, nausea, and sweating. 'A couple of sips and they're dizzy and flushed' — that's the classic ALDH2*2 carrier picture.
This isn't 'intolerance' — it's 'acetaldehyde piling up in the blood'. For the same drink, the carrier's blood acetaldehyde peak can reach 6–10× the non-carrier's (Yokoyama 2007). Acetaldehyde is an IARC Group 1 carcinogen and forms DNA adducts, so that 6–10× translates directly into 6–10× the actual carcinogen exposure.
Clinical consequences:
Esophageal cancer — daily-drinking ALDH2*2 carriers face 50–80× higher esophageal squamous-cell carcinoma risk vs non-carrier non-drinkers (Yokoyama 2002 NEJM), one of the strongest known gene–environment interactions in human diseaseHead-and-neck and gastric cancer — same direction, 5–20× elevationsCoronary heart disease — some studies show elevated risk; the mechanism is likely acetaldehyde damage to vascular endothelium, plus ALDH2 also plays a role in cardiac metabolism of nitroglycerin, so carriers see blunted efficacy of the emergency drugWomen + carrier + drinking — elevated osteoporosis risk
Practical implications, especially relevant for Chinese / Japanese / Korean readers:
If you flush when you drink, you're very likely an ALDH2*2 carrier'Drinking to build tolerance' is the wrong concept here — what people call tolerance is brain adaptation to ethanol (GABA receptor down-regulation), but the acetaldehyde in your blood is unchanged, so the carcinogenic damage is the same or worseThere is no antidote: no nutritional supplement can restore ALDH2 activity (it's genetic), and every 'ALDH2 booster' on the market is marketing languageThe only effective intervention is dramatically reducing or stopping drinkingClinically, disulfiram (Antabuse) — an ALDH2 inhibitor — is used as alcoholism therapy, which is essentially proof that this reaction itself functions as a deterrent
Bottom line is direct: if you're East Asian and flush when you drink, that isn't 'weakness' — it's your body's protective mechanism still working. It's an evolutionary-level warning written in your genes; don't try to override it with willpower.
ALDH2 in the heart · nitroglycerin
ALDH2 isn't only the liver's acetaldehyde-handler — in the heart it also metabolizes nitroglycerin (NTG). Nitroglycerin has been the sublingual emergency tablet for angina since 1879, and its mechanism is to release nitric oxide (nitric oxide: A small signal molecule from the vessel lining that relaxes the vessel-wall muscle so the vessel widens.) and dilate the coronary arteries to relieve chest pain — but that step inside the vessel wall requires ALDH2 to activate NTG (Chen 2002 PNAS, Beretta 2008).So ALDH2*2 carriers (30–40% of East Asians) see their NTG response fall by 30–50%, and emergency drug efficacy may be inadequate during acute chest pain.
Clinically, several things matter:
During an acute angina attack, ALDH2*2 carriers may need alternative drugs, such as isosorbide dinitrate or other NO-delivery methodsEast Asian coronary-disease patients ideally know their ALDH2 genotype and have discussed emergency strategy with cardiology in advanceMost people won't actively test, but 'flushing on alcohol' is a free phenotypic screen — it can't distinguish heterozygote from homozygote, but it does confirm carrier status
ALDH2 also metabolizes several drugs and endogenous aldehydes (e.g. the lipid peroxidation product 4-HNE) and is linked to diabetic cardiomyopathy (Chen 2014 Lancet). Small-molecule activators like Alda-1 are still in research and far from clinical use.
Practical:
If ALDH2*2 + cardiovascular disease, discuss emergency-drug choices with cardiologyWhatever the situation, don't trust 'ALDH2-enhancing supplements' — Polygonum cuspidatum, resveratrol, kudzu, and L-cysteine cannot reverse a genetic mutationALDH2 genotyping is available on 23andMe, WeGene, and many general health panels for tens of yuan
This scene has a special place on the atlas: ALDH2 is the first teaching example of 'one mutation, dual clinical meaning' — the same molecule plays a decisive role in both alcohol-related cancer and the efficacy of an emergency drug, sitting at the intersection of nutrition, pharmacology, and genetics.
Chapter 4
The J-curve is dead
The J-curve is dead
'A glass of red wine a day protects the heart' was one of the most influential health myths of the past 30 years, and 2018–2022 evidence has thoroughly overturned it.
The J-curve hypothesis came from 1990s observational cohorts: early Framingham and Nurses' Health Study data showed light drinkers had the lowest all-cause mortality, with the curve in a J-shape (high at non-drinkers and heavy drinkers, low in the middle). Combined with the 'resveratrol / polyphenols / raised HDL / improved coagulation' mechanism story, media echoed it until the public accepted it as 'scientific consensus'.
The problem is the J-curve was largely a statistical illusion. Going through the data flaws point by point:
First, the 'non-drinker' group was a confounded pool (Stockwell 2016 J Stud Alcohol Drugs). The 'never drinks' category mixed in 'sick quitters' — people who had already stopped because of liver disease, cancer, or heart disease, who were sick from the start, and whose mortality was naturally high; mixed with true lifetime abstainers, this manufactured a fake 'high non-drinker mortality'. With strict separation, true lifelong abstainers do not have elevated mortality.
Second, healthy-user bias. Moderate drinkers tend to have higher socioeconomic status, more exercise, better diets, and more medical visits; these confounders are partly controllable, but residual confounding is enough to explain most of the J-curve.
Third, reverse causation. People whose health is deteriorating reduce their drinking voluntarily — the causal direction was flipped.
Later key studies dismantled the J-curve: GBD 2018 Lancet (Griswold + Burton, meta of 295 studies across 195 countries) gave 'minimum-risk drinking level = 0 g/day', netting cancer, injury, and cardiovascular effects together — any dose carries measurable health cost; Anderson 2022 JAMA Netw Open used Mendelian randomization in UK Biobank N = 371,463 and showed genetic propensity to higher drinking raises cardiovascular and all-cause mortality risk linearly, with no J shape at all; Burton & Sheron 2018 Lancet wrote plainly 'no safe level of alcohol consumption'.
The new round of guidelines has followed: WHO 2023 explicitly states 'no safe level of alcohol consumption'; Canada 2023 classifies 1–2 drinks/week as low risk and 7+ drinks/week as high risk; US USPSTF / CDC still hold the old standard of ≤ 2 drinks/day for men and ≤ 1 for women but are updating; the UK from 2016 has used a unified ≤ 14 units/week for both sexes (about 6 cans of 5% beer).
Bottom line in three sentences: 'red wine protects the heart' is wrong, and the polyphenols in red wine can come from grapes, blueberries, tea, chocolate, and olive oil without the ethanol; 'moderate drinking' has no unified threshold and any reduction at any level helps; complete abstention is best for health — but whether to do so is your own choice, and the atlas here just lays out the evidence.
The J-curve hypothesis came from 1990s observational cohorts: early Framingham and Nurses' Health Study data showed light drinkers had the lowest all-cause mortality, with the curve in a J-shape (high at non-drinkers and heavy drinkers, low in the middle). Combined with the 'resveratrol / polyphenols / raised HDL / improved coagulation' mechanism story, media echoed it until the public accepted it as 'scientific consensus'.
The problem is the J-curve was largely a statistical illusion. Going through the data flaws point by point:
First, the 'non-drinker' group was a confounded pool (Stockwell 2016 J Stud Alcohol Drugs). The 'never drinks' category mixed in 'sick quitters' — people who had already stopped because of liver disease, cancer, or heart disease, who were sick from the start, and whose mortality was naturally high; mixed with true lifetime abstainers, this manufactured a fake 'high non-drinker mortality'. With strict separation, true lifelong abstainers do not have elevated mortality.
Second, healthy-user bias. Moderate drinkers tend to have higher socioeconomic status, more exercise, better diets, and more medical visits; these confounders are partly controllable, but residual confounding is enough to explain most of the J-curve.
Third, reverse causation. People whose health is deteriorating reduce their drinking voluntarily — the causal direction was flipped.
Later key studies dismantled the J-curve: GBD 2018 Lancet (Griswold + Burton, meta of 295 studies across 195 countries) gave 'minimum-risk drinking level = 0 g/day', netting cancer, injury, and cardiovascular effects together — any dose carries measurable health cost; Anderson 2022 JAMA Netw Open used Mendelian randomization in UK Biobank N = 371,463 and showed genetic propensity to higher drinking raises cardiovascular and all-cause mortality risk linearly, with no J shape at all; Burton & Sheron 2018 Lancet wrote plainly 'no safe level of alcohol consumption'.
The new round of guidelines has followed: WHO 2023 explicitly states 'no safe level of alcohol consumption'; Canada 2023 classifies 1–2 drinks/week as low risk and 7+ drinks/week as high risk; US USPSTF / CDC still hold the old standard of ≤ 2 drinks/day for men and ≤ 1 for women but are updating; the UK from 2016 has used a unified ≤ 14 units/week for both sexes (about 6 cans of 5% beer).
Bottom line in three sentences: 'red wine protects the heart' is wrong, and the polyphenols in red wine can come from grapes, blueberries, tea, chocolate, and olive oil without the ethanol; 'moderate drinking' has no unified threshold and any reduction at any level helps; complete abstention is best for health — but whether to do so is your own choice, and the atlas here just lays out the evidence.
Cancer · IARC Group 1
Alcohol is an IARC (International Agency for Research on Cancer) Group 1 carcinogen, in the same class as tobacco, asbestos, and formaldehyde. This is not a disputed call — it has been a clear classification since 1988.Alcohol-related cancers (Bagnardi 2015 BJC meta + GBD 2020):
Oral / pharyngeal / esophageal squamous-cell carcinoma — risk rises linearly with dose; heavy drinkers see 2–8× elevationsBreast cancer (women) — every additional 10 g/day of ethanol raises breast cancer risk 7–10%; this is the most sensitive association and has no safe thresholdColorectal cancer — every 10 g/day adds 5% riskLiver cancer — heavy drinkers see 2–3× elevations (built on a cirrhotic background)Gastric cancer — heavy drinking + Helicobacter pylori stack synergistically
Mechanistically several pathways each contribute: acetaldehyde itself is IARC Group 1, forms DNA adducts, and directly damages DNA to let mutations accumulate; CYP2E1-pathway-induced oxidative stress drives chronic inflammation and damage; altered estrogen levels partially explain breast cancer in women; chronic drinking causes folate / B12 / B6 / Zn absorption and utilization problems, dysregulated methylation, and impaired DNA repair; IGF-1, estrogen, and androgen signaling are also disrupted.
The ALDH2*2 carriers in East Asia, as the previous scene covered: esophageal cancer risk rises 50–80×, one of the strongest known gene–environment interactions in human disease.
WHO 2023 (Lancet Public Health) put it plainly:
> 'For cancer risk, there is no known safe level of alcohol consumption — risk begins from the first drop.'
Practical guidance:
Complete abstention carries the lowest cancer riskHeavy drinkers see partial risk reversal after quitting (oral / esophageal ~10 years, liver 5–10 years, breast persists for longer)Women with a breast-cancer family history or BRCA mutation should be cautious at any drinking levelEast Asians + ALDH2*2 + still drinking should consider early endoscopic screening for esophageal cancer
Chapter 5
Nutrition + decision
Nutrition + decision
If you choose to drink, nutrition can do limited but not zero work.
Before and during drinking:
Food first: a mixed meal of fat + protein + carbs halves gastric emptying, blunting the blood-ethanol peak and giving the liver more breathing roomDon't drink on an empty stomach: the ethanol peak is higher and hypoglycemia risk adds danger, especially for diabeticsDilute the drink: a shot mixed into plenty of water or soda doesn't change ethanol grams but slows the peakMatch with water: one drink + one water, reducing the burst presented to the liverAvoid ALDH2-inhibitor drugs: do not drink while on cephalosporin antibiotics, griseofulvin, metronidazole, or disulfiram
On 'hangover cures' sold in the market, evidence stacks up like this:
No drug or supplement can speed ADH / ALDH2 — the rate is enzyme-saturated, more substrate doesn't speed it upResveratrol / kudzu / Polygonum cuspidatum / artichoke / reishi / honey: clinical evidence is essentially absentNAC (N-acetylcysteine): theoretically a glutathione precursor, with some support for severe-drinking liver rescue (analogous to acetaminophen toxicity), but weak evidence for preventing or relieving hangoverB1 (thiamine): chronic drinkers with established deficiency need this to prevent Wernicke-Korsakoff syndrome — that's an ER-level intervention (100 mg IV), not a daily hangover toolExercise / sweating / sauna 'detox': completely ineffective. Ethanol is 90%+ cleared by hepatic metabolism; sweat + urine combined account for under 10%
Even chronic drinkers without cirrhosis have several nutritional risks worth remembering: B1 (thiamine) deficiency drives Wernicke-Korsakoff syndrome (amnesia + ataxia), an emergency drug indication; folate / B12 / B6 / Zn / Mg / K deficiency cause methylation disorders, neuropathy, and arrhythmias; vitamin D and calcium deficits drive osteoporosis and falls; plus protein wasting + sarcopenia; rising NADH suppresses urate excretion, so gout and hyperuricemia follow.
When it comes to decisions, you can use this branching:
Want to quit entirely: maximum health benefit, all risks down; difficulty depends on dependence levelWant to cut down: any reduction helps — target 50% rather than insisting on 100%East Asian + flushes + still drinking: doubled esophageal / head-and-neck cancer risk — strongly cut and have periodic endoscopyPregnant / planning pregnancy: zero alcohol — fetal alcohol spectrum disorders (FASD) has no safe thresholdOn medications: check drug interactions first (cephalosporins, metronidazole, Tylenol, benzodiazepines, SSRIs all have varying degrees of interaction)Family history of liver disease / pancreatitis / breast cancer / esophageal cancer: risk multiplies significantly — cut or stop
So the atlas position on this island stays the same: not anti-alcohol moralizing, just mechanism and evidence laid out clearly. 'I understand the risk, I choose to drink' is a legitimate stance; 'I didn't know — I drank for 20 years before learning' is what we want to help you avoid. Informed autonomy is Fitnuhealth's commitment.
Before and during drinking:
Food first: a mixed meal of fat + protein + carbs halves gastric emptying, blunting the blood-ethanol peak and giving the liver more breathing roomDon't drink on an empty stomach: the ethanol peak is higher and hypoglycemia risk adds danger, especially for diabeticsDilute the drink: a shot mixed into plenty of water or soda doesn't change ethanol grams but slows the peakMatch with water: one drink + one water, reducing the burst presented to the liverAvoid ALDH2-inhibitor drugs: do not drink while on cephalosporin antibiotics, griseofulvin, metronidazole, or disulfiram
On 'hangover cures' sold in the market, evidence stacks up like this:
No drug or supplement can speed ADH / ALDH2 — the rate is enzyme-saturated, more substrate doesn't speed it upResveratrol / kudzu / Polygonum cuspidatum / artichoke / reishi / honey: clinical evidence is essentially absentNAC (N-acetylcysteine): theoretically a glutathione precursor, with some support for severe-drinking liver rescue (analogous to acetaminophen toxicity), but weak evidence for preventing or relieving hangoverB1 (thiamine): chronic drinkers with established deficiency need this to prevent Wernicke-Korsakoff syndrome — that's an ER-level intervention (100 mg IV), not a daily hangover toolExercise / sweating / sauna 'detox': completely ineffective. Ethanol is 90%+ cleared by hepatic metabolism; sweat + urine combined account for under 10%
Even chronic drinkers without cirrhosis have several nutritional risks worth remembering: B1 (thiamine) deficiency drives Wernicke-Korsakoff syndrome (amnesia + ataxia), an emergency drug indication; folate / B12 / B6 / Zn / Mg / K deficiency cause methylation disorders, neuropathy, and arrhythmias; vitamin D and calcium deficits drive osteoporosis and falls; plus protein wasting + sarcopenia; rising NADH suppresses urate excretion, so gout and hyperuricemia follow.
When it comes to decisions, you can use this branching:
Want to quit entirely: maximum health benefit, all risks down; difficulty depends on dependence levelWant to cut down: any reduction helps — target 50% rather than insisting on 100%East Asian + flushes + still drinking: doubled esophageal / head-and-neck cancer risk — strongly cut and have periodic endoscopyPregnant / planning pregnancy: zero alcohol — fetal alcohol spectrum disorders (FASD) has no safe thresholdOn medications: check drug interactions first (cephalosporins, metronidazole, Tylenol, benzodiazepines, SSRIs all have varying degrees of interaction)Family history of liver disease / pancreatitis / breast cancer / esophageal cancer: risk multiplies significantly — cut or stop
So the atlas position on this island stays the same: not anti-alcohol moralizing, just mechanism and evidence laid out clearly. 'I understand the risk, I choose to drink' is a legitimate stance; 'I didn't know — I drank for 20 years before learning' is what we want to help you avoid. Informed autonomy is Fitnuhealth's commitment.
Pregnancy · zero tolerance
Fetal Alcohol Spectrum Disorder (FASD) is the one topic on the atlas where every guideline reaches 'zero threshold' consensus.The mechanism is direct: ethanol and acetaldehyde cross the placenta freely with no barrier; the fetal liver expresses almost no ADH / ALDH2 and won't have full function until ~6 months after birth. The result: fetal exposure concentration is roughly equal to maternal concentration, but lasts about 2× as long. Once damage hits during the critical developmental window (weeks 8–25 are especially sensitive), it is permanent and irreversible.
FASD isn't a single point but a spectrum:
Severe FAS (Fetal Alcohol Syndrome): characteristic facies (flat philtrum + thin upper lip + narrow palpebral fissures) + growth retardation + severe neurodevelopmental disability (IQ drop 30–50)Milder ARND (Alcohol-Related Neurodevelopmental Disorder): no facial features but learning difficulties + attention and executive function problemsOverall, US FASD prevalence is estimated at 1–5% (Roozen 2016 meta), far higher than autism
Is 'an occasional glass during pregnancy' safe? No scientific evidence shows any dose is safe. CDC, WHO, NICE, and SOGC all recommend complete zero alcohol from preconception through pregnancy and breastfeeding. 'Red wine for iron' is wrong and dangerous during pregnancy — don't.
Preconception details worth mentioning: in the first 4 weeks after conception the mother may not yet know she's pregnant — so stop drinking the moment you start trying, don't wait for a positive test. Paternal preconception drinking also carries risk (sperm DNA damage + epigenetic modifications); a 3-month dry preconception window is advised.
This section drops the usual atlas 'point-by-point debunk' tone and is direct: FASD is fully preventable, fully irreversible once it occurs, and the only effective intervention is not drinking. Traditional claims like 'red wine for blood', 'rice wine for milk supply', or 'yellow wine for damp' have no evidence base. While breastfeeding, one drink puts milk ethanol roughly equal to blood — wait at least 2 hours before feeding, or pump and discard.